| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| OR11A1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423230 | 1 kit | ORIGENE TECHNOLOGIES |
| OR14A16 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN421649 | 1 kit | ORIGENE TECHNOLOGIES |
| OR7A10 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN422070 | 1 kit | ORIGENE TECHNOLOGIES |
| OR52A1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423453 | 1 kit | ORIGENE TECHNOLOGIES |
| OR10A7 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423908 | 1 kit | ORIGENE TECHNOLOGIES |
| OR5A2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN424012 | 1 kit | ORIGENE TECHNOLOGIES |
| OR2A4 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN423604 | 1 kit | ORIGENE TECHNOLOGIES |
| OR3A2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN424519 | 1 kit | ORIGENE TECHNOLOGIES |
| OR2A7 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN424346 | 1 kit | ORIGENE TECHNOLOGIES |
| OR56A5 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN428246 | 1 kit | ORIGENE TECHNOLOGIES |
| Oral cancer overexpressed 1 (ORAOV1) from ORIGENE TECHNOLOGIES | LY407037 | 100 ug | ORIGENE TECHNOLOGIES |
| Oral-facial-digital syndrome 1 (OFD1) from ORIGENE TECHNOLOGIES | LY418551 | 100 ug | ORIGENE TECHNOLOGIES |
| RS1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN414267 | 1 kit | ORIGENE TECHNOLOGIES |
| Rs1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN515152 | 1 kit | ORIGENE TECHNOLOGIES |
| Ladinin 1 (LAD1) from ORIGENE TECHNOLOGIES | LY401704 | 100 ug | ORIGENE TECHNOLOGIES |
| LAD1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN413031 | 1 kit | ORIGENE TECHNOLOGIES |
| Lad1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN509102 | 1 kit | ORIGENE TECHNOLOGIES |
| LAD1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH313031 | 10 ug | ORIGENE TECHNOLOGIES |
| Ladybird homeobox 1 (LBX1) from ORIGENE TECHNOLOGIES | LY416561 | 100 ug | ORIGENE TECHNOLOGIES |
| Laeverin (LVRN) from ORIGENE TECHNOLOGIES | LY406576 | 100 ug | ORIGENE TECHNOLOGIES |
| Human IFN-a ELISA Kit (48-well) from ORIGENE TECHNOLOGIES | EA100087 | 48-well strip plate | ORIGENE TECHNOLOGIES |
| Human IFN-a ELISA Kit (96-well) from ORIGENE TECHNOLOGIES | EA100088 | 96-well strip plate | ORIGENE TECHNOLOGIES |
| Putative homeodomain transcription factor 1 (PHTF1) from ORIGENE TECHNOLOGIES | LY416532 | 100 ug | ORIGENE TECHNOLOGIES |
| Putative homeodomain transcription factor 2 (PHTF2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY412482 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 10 (P2RY10), transcript variant 1 from ORIGENE TECHNOLOGIES | LY415234 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 10 (P2RY10), transcript variant 2 from ORIGENE TECHNOLOGIES | LY405022 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 12 (P2RY12), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402949 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 12 (P2RY12), transcript variant 2 from ORIGENE TECHNOLOGIES | LY403587 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 13 (P2RY13), transcript variant 1 from ORIGENE TECHNOLOGIES | LY402959 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 13 (P2RY13), transcript variant 1 from ORIGENE TECHNOLOGIES | LY429721 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 14 (P2RY14), transcript variant 1 from ORIGENE TECHNOLOGIES | LY421155 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 14 (P2RY14), transcript variant 2 from ORIGENE TECHNOLOGIES | LY414966 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 2 (P2RY2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY403585 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 2 (P2RY2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY419246 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 2 (P2RY2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY406218 | 100 ug | ORIGENE TECHNOLOGIES |
| Purinergic receptor P2Y, G-protein coupled, 2 (P2RY2), transcript variant 3 from ORIGENE TECHNOLOGIES | LY430446 | 100 ug | ORIGENE TECHNOLOGIES |
| Purine-rich element binding protein A (PURA) from ORIGENE TECHNOLOGIES | LY417029 | 100 ug | ORIGENE TECHNOLOGIES |
| Purine-rich element binding protein B (PURB) from ORIGENE TECHNOLOGIES | LY409642 | 100 ug | ORIGENE TECHNOLOGIES |
| Purine-rich element binding protein G (PURG), transcript variant A from ORIGENE TECHNOLOGIES | LY415660 | 100 ug | ORIGENE TECHNOLOGIES |
| Purine-rich element binding protein G (PURG), transcript variant B from ORIGENE TECHNOLOGIES | LY423125 | 100 ug | ORIGENE TECHNOLOGIES |
| Purine-rich element binding protein G (PURG), transcript variant B from ORIGENE TECHNOLOGIES | LY425386 | 100 ug | ORIGENE TECHNOLOGIES |
| Purkinje cell protein 4 like 1 (PCP4L1) from ORIGENE TECHNOLOGIES | LY426183 | 100 ug | ORIGENE TECHNOLOGIES |
| Purkinje cell protein 2 (PCP2) from ORIGENE TECHNOLOGIES | LY403562 | 100 ug | ORIGENE TECHNOLOGIES |
| Purkinje cell protein 4 (PCP4) from ORIGENE TECHNOLOGIES | LY416805 | 100 ug | ORIGENE TECHNOLOGIES |
| Multiple coagulation factor deficiency 2 (MCFD2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY408335 | 100 ug | ORIGENE TECHNOLOGIES |
| Multiple EGF-like-domains 6 (MEGF6) from ORIGENE TECHNOLOGIES | LY419949 | 100 ug | ORIGENE TECHNOLOGIES |
| Multiple EGF-like-domains 10 (MEGF10) from ORIGENE TECHNOLOGIES | LY410139 | 100 ug | ORIGENE TECHNOLOGIES |
| Multiple endocrine neoplasia I (MEN1), transcript variant 2 from ORIGENE TECHNOLOGIES | LY408952 | 100 ug | ORIGENE TECHNOLOGIES |
| Multiple inositol polyphosphate histidine phosphatase, 1 (MINPP1) from ORIGENE TECHNOLOGIES | LY417667 | 100 ug | ORIGENE TECHNOLOGIES |
| Multiple endocrine neoplasia I (MEN1), transcript variant e1D from ORIGENE TECHNOLOGIES | LY408955 | 100 ug | ORIGENE TECHNOLOGIES |